Browsing: Danaher

Topline Washington, D.C.-based drugmaker Danaher has agreed to lower the cost of test cartridges used to diagnose tuberculosis by 20%…

Danaher Corp (NYSE: DHR) has logged Q1 FY23 adjusted EPS of $2.36, down from $2.76 a year ago, surpassing the consensus of $2.25.Sales decreased…